Michael J. McGann - 01 Mar 2026 Form 4 Insider Report for Xylem Inc. (XYL)

Role
EVP & President, MCS
Signature
/s/ Mike Nazario, by power of attorney for Michael J. McGann
Issuer symbol
XYL
Transactions as of
01 Mar 2026
Net transactions value
+$1,047,705
Form type
4
Filing time
03 Mar 2026, 16:56:43 UTC
Previous filing
06 Mar 2025
Next filing
06 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McGann Michael J. EVP & President, MCS C/O XYLEM INC., 301 WATER STREET SE, WASHINGTON /s/ Mike Nazario, by power of attorney for Michael J. McGann 03 Mar 2026 0001962070

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XYL Common Stock Award $253,575 +1,966 +24% $128.98 10,197 01 Mar 2026 Direct F1, F2
transaction XYL Common Stock Award $209,206 +1,622 +16% $128.98 11,819 01 Mar 2026 Direct F3
transaction XYL Common Stock Award $142,265 +1,103 +9.3% $128.98 12,922 01 Mar 2026 Direct F4
transaction XYL Common Stock Award $63,071 +489 +3.8% $128.98 13,411 01 Mar 2026 Direct F5
transaction XYL Common Stock Award $0 +1,610 +12% $0.000000 15,021 02 Mar 2026 Direct F6
transaction XYL Common Stock Tax liability $267,376 -2,073 -14% $128.98 12,948 02 Mar 2026 Direct F7
transaction XYL Common Stock Tax liability $27,473 -213 -1.6% $128.98 12,735 02 Mar 2026 Direct F8
transaction XYL Common Stock Tax liability $65,780 -510 -4% $128.98 12,225 02 Mar 2026 Direct F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XYL Non-Qualified Stock Options (Right to Buy) Award $740,216 +5,739 $128.98 5,739 02 Mar 2026 Common Stock 5,739 $128.98 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the acquisition of 1,966 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.
F2 Includes additional shares due to dividend reinvestment.
F3 Reflects the acquisition of 1,622 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.
F4 Reflects the acquisition of 1,103 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.
F5 Reflects the acquisition of 489 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance.
F6 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
F7 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).
F8 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).
F9 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (269) and March 1, 2024 (241) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
F10 Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.